We are live on ! Find out more
Schroder Investment Management Group

Schroder Investment Management Group Portfolio holdings

AUM $122B
1-Year Est. Return 29.27%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$37.8B
AUM Growth
Cap. Flow
+$38.1B
Cap. Flow %
100.76%
Top 10 Hldgs %
12.48%
Holding
1,431
New
1,431
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$613M
2
MSFT icon
Microsoft
MSFT
+$558M
3
ITUB icon
Itaú Unibanco
ITUB
+$507M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$492M
5
SU icon
Suncor Energy
SU
+$423M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 16.2%
2 Healthcare 13.94%
3 Technology 12.07%
4 Industrials 9.76%
5 Energy 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PBCT
1026
DELISTED
People's United Financial Inc
PBCT
$827K ﹤0.01%
+55,477
New +$757K
FFIV icon
1027
F5
FFIV
$22.7B
$826K ﹤0.01%
+12,000
New +$923K
CDE icon
1028
Coeur Mining
CDE
$17.9B
$821K ﹤0.01%
+61,700
New +$898K
ANH
1029
DELISTED
Anworth Mortgage Asset Corporation
ANH
$801K ﹤0.01%
+142,992
New +$849K
LUV icon
1030
Southwest Airlines
LUV
$23B
$798K ﹤0.01%
+61,900
New +$844K
ZTS icon
1031
Zoetis
ZTS
$30B
$797K ﹤0.01%
+25,790
New +$835K
FLG
1032
Flagstar Bank National Association
FLG
$5.82B
$788K ﹤0.01%
+18,764
New +$761K
TIS
1033
DELISTED
Orchids Paper Products, Inc.
TIS
$785K ﹤0.01%
+29,900
New +$719K
REGN icon
1034
Regeneron Pharmaceuticals
REGN
$80.8B
$779K ﹤0.01%
+3,464
New +$807K
CM icon
1035
Canadian Imperial Bank of Commerce
CM
$108B
$778K ﹤0.01%
+22,445
New +$842K
JBL icon
1036
Jabil
JBL
$35.8B
$772K ﹤0.01%
+37,900
New +$715K
FLEX icon
1037
Flex
FLEX
$44.8B
$770K ﹤0.01%
+132,037
New +$717K
CAG icon
1038
Conagra Brands
CAG
$7.23B
$769K ﹤0.01%
+28,305
New +$766K
KRE icon
1039
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
$769K ﹤0.01%
+22,690
New +$725K
CPB icon
1040
Campbell Soup
CPB
$6.87B
$767K ﹤0.01%
+17,132
New +$778K
BMRN icon
1041
BioMarin Pharmaceuticals
BMRN
$12.4B
$761K ﹤0.01%
+13,644
New +$850K
TTC icon
1042
Toro Company
TTC
$9.49B
$749K ﹤0.01%
+33,000
New +$760K
CBRL icon
1043
Cracker Barrel
CBRL
$1.29B
$748K ﹤0.01%
+7,900
New +$688K
IWM icon
1044
iShares Russell 2000 ETF
IWM
$83B
$747K ﹤0.01%
+7,700
New +$735K
CLX icon
1045
Clorox
CLX
$12.7B
$746K ﹤0.01%
+8,970
New +$772K
CAAS icon
1046
China Automotive Systems
CAAS
$133M
$744K ﹤0.01%
+144,521
New +$709K
CCU icon
1047
Compañía de Cervecerías Unidas
CCU
$2.21B
$741K ﹤0.01%
+25,900
New +$788K
TRI icon
1048
Thomson Reuters
TRI
$44.1B
$733K ﹤0.01%
+19,405
New +$751K
VRTX icon
1049
Vertex Pharmaceuticals
VRTX
$126B
$729K ﹤0.01%
+9,110
New +$671K
FIBK icon
1050
First Interstate BancSystem
FIBK
$3.58B
$728K ﹤0.01%
+35,100
New +$693K

Similar funds

Schroder Investment Management Group's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Schroder Investment Management Group, which disclosed 1,431 positions worth $37.8B. Its ten largest holdings account for 12% of the portfolio.

Its largest position is Pfizer: 22,181,689 shares worth $589M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Healthcare and Technology.

  • Schroder Investment Management Group's largest Q2 2013 buy was Pfizer: 22,181,689 shares worth $589M.
  • Schroder Investment Management Group's ten largest holdings make up 12% of its $37.8B portfolio in Q2 2013.
  • Schroder Investment Management Group disclosed 1,431 positions in Q2 2013, its first 13F filing on record.

Based on Schroder Investment Management Group's 13F filing for Q2 2013, filed 12 Aug 2013.